Pfizer Shares Rise on Celebrex, Aleve Trial Data
261035
Pfizer Inc. shares rebounded on Tuesday as a study of Alzheimer&#39;s patients found that its arthritis drug Celebrex carried no increased cardiovascular risks, differing from
421295
U.S. stocks rose on Monday as several major corporate deals pointed to optimism about the economy, outweighing sharp losses by blue-chip Pfizer Inc.  after the world's No. 1 drug company dropped a key experimental product.
114399
Pfizer Inc., the world&#39;s biggest drugmaker, defended its painkiller Celebrex after a researcher&#39;s suggestion the medication may be linked to heart risks sent the stock down as much as 8.3 percent.
342189
Shares of Pfizer (PFE:NYSE - news - research) dropped Thursday after a Canadian newspaper reported that the arthritis drug Celebrex is &quot;suspected of contributing to at least 14 deaths.
574939
Pfizer Inc , the world's biggest drugmaker, on Wednesday reported fourth-quarter results that beat expectations.
494835
Shares of drug company AtheroGenics Inc. opened up 81 percent Tuesday morning and remained at high levels after the company revealed promising clinical data late Monday for a drug to treat hardening arteries.
84184
As the Food and Drug Administration prepares to make recommendations about Pfizer&#39;s (PFE:NYSE - news - research) Celebrex, the companies that ultimately pay for the drug aren&#39;t leaping to conclusions merely because one recent study showed patients taking
693310
The Pfizer painkillers Celebrex and Bextra experienced a jump in sales immediately after rival Merck&#39;s Vioxx was pulled from the market in late September, but the gains appear to be short
363593
Oil prices held steady above &#36;46 and most Asian stock markets edged higher on Monday, but Japanese pharmaceutical shares fell after U.S. drug maker Pfizer reported safety risks for its Celebrex arthritis drug.
768648
Oil prices held steady above $46 and  most Asian stock markets edged higher on Monday, but Japanese  pharmaceutical shares fell after U.S. drug maker Pfizer  reported safety risks for its Celebrex arthritis drug.
726208
Pfizer Inc.   raised its 2006 profit forecast on Thursday and said  its roster of experimental drugs in late-stage testing could  triple by 2009, sending its shares higher.
637430
Pfizer shares plunged in blizzard-like trading volume Friday after the drugmaker said new data from cancer trials showed its arthritis drug Celebrex posed &quot;increased cardiovascular risk&quot; when used in high doses.
478882
Pfizer (PFE) said Friday that is has received new information about the cardiovascular safety of its popular arthritis drug Celebrex, based on an analysis of a long-term cancer trial.
336646
US drug giant Pfizer has said a trial had found a sharp rise in heart attacks for patients using its Celebrex arthritis and pain medicine but it would not immediately withdraw the treatment.
422800
NEW YORK, December 30  - New prescriptions for pharmaceutical major Pfizerâs (PFE.NYS) arthritis drug Celebrex declined 56% last week after the company revealed that the regular usage of the drug could enhance the risk of heart attacks
482981
NEW YORK - Pfizer Inc. said it found an increased risk of heart attacks for patients taking high dosages of its top-selling painkiller Celebrex, the same problem that led to the withdrawal of its one-time competitor Vioxx.
644599
Pharmaceutical giant Pfizer Inc. will announce plans for a large-scale clinical trial of the ability of blockbuster drug Celebrex to prevent heart attacks and strokes in patients with